TrialRheumatology (Oxford, England)2024

Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab.

Leonardo Palazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.